Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter, and thyroid cancer

Clinical Chemistry

Volumn 42, Issue 1, 1996, Pages 183-187

  Ladenson, Paul W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

calcitonin; oncogenes; thyroglobulin; thyroid status; thyrotropin

Indexed keywords

AUTOANTIBODY; CALCITONIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

AUTOIMMUNITY; CONFERENCE PAPER; DIAGNOSIS; DIAGNOSTIC ACCURACY; GOITER; HASHIMOTO DISEASE; HORMONE DETERMINATION; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; PATHOGENESIS; THYROID CANCER; THYROID NODULE; THYROTROPIN BLOOD LEVEL;

EID: 0030061669     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.1.183     Document Type: Conference Paper

References (27)

1. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules: final report of a 15 year study of the incidence of thyroid malignancy. Ann Intern Med 1968;69:537-40.
2. Bruneton JN, Balu-Maestro C, Marcy PY, Melia P, Mourou MY. Very high frequency (13 MHz) ultrasonographic examination of the normal neck: detection of normal lymph nodes and thyroid nodules. J Ultrasound Med 1994;13:87-90.
3. Smallridge RC. Thyrotropin-secreting pituitary tumors. Endocrinol Metab Clin North Am 1987;16:765-92.
4. Refetoff S. Resistance to thyroid hormone: an historical overview. Thyroid 1994;4:345-9.
5. Pekary AE, Jackson IM, Goodwin TM, Pang XP, Hein MD, Hershman JM. Increased in vitro thyrotropic activity of partially sialylated human chorionic gonadotropin extracted from hydatidiform moles of patients with hyperthyroidism. J Clin Endocrinol Metab 1993; 76:70-4.
6. Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 1992;75:1333-7.
7. McDougall IR. Graves' disease. Med Clin North Am 1991;75:79-95.
8. Brown RS. Immunoglobulins affecting thyroid growth: a continuing controversy [Editorial]. J Clin Endocrinol Metab 1995;80:1506-8.
9. Duh QY, Grossman RF. Thyroid growth factors, signal transduction pathway, and oncogenes. Surg Clin North Am 1995;75:421-37.
10. Yoshinari M, Tokuyama T, Kuroda T, Sato K, Okazawa K, Mizokami T, et al. Preserved thyroidal secretion of thyroxine in acromegalic patients with suppressed hypophyseal secretion of thyrotrophin. CMn Endocrinol (Oxf) 1992;36:355-60.
11. Parma J, Duprez L, Van Sande J, Cochaux D, Gervy C, Mockel J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993;365:649-51.
12. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE. Novel mutations of thyrotropin receptor gene in hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J Clin Endocrinol Metab 1994;79:657-61.
13. Karga H, Lee J-K, Vickery AL, Thor A, Gaz RD, Jameson JL. Ras oncogene mutations in benign and malignant thyroid neoplasms. J Clin Endocrinol Metab 1991;73:832-6.
14. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 1990;60:557-63.
15. Fagin JA, Matsuo K, Karmarkar A, Chen DL, Tang SH, Koeffler HP. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 1992;91:179-84.
16. Ridgway EC, Weintraub BD, Cevallos JL, Rack MC, Maloof F. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J Clin Invest 1973;52:2783-92.
17. Hay ID, Klee GG. Thyroid cancer diagnosis and management. Clin Lab Med 1993;13:725-34.
18. Goldstein BJ, Mushlin AI. Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism. J Gen Intern Med 1987;2:20-4.
19. Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A. Antithyroid peroxidase autoantibodies in thyroid disease. J Clin Endocrinol Metab 1990;71:661-9.
20. Beever K, Bradbury J, Phillips D, McLachlan SM, Pegg C, Goral A, et al. Highly sensitive assay of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem 1989;35:1949-54.
21. Silverman JF, Khazanie PG, Norris HT, Fore WW. Parathyroid hormone (PTH) assay of parathyroid cysts examined by fine-needle aspiration biopsy. Am J Clin Pathol 1986;86:776-80.
22. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for assays of serum thyrotropin. Clin Chem 1996;42: in press
23. Ronga G, Fiorentino A, Paserio E, Signore A, Todino V, Tummarello MA, et al. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma? J Nucl Med 1990;31:1766-71.
24. Dadparvar S, Krishna L, Brady LW, Slizofski WJ, Brown SJ, Chevres A, Micaily B. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid cancer. Cancer 1993;71:3767-73.
25. Lubin E, Mechlis-Frish S, Zatz S, Shimorri A, Segal K, Avraham A, et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 1994;35:257-62.
26. Wells SA Jr, Dilley WG, Farndon JA, Leight GS, Baylin SB. Early diagnosis and treatment of medullary thyroid cancer. Arch Intern Med 1985;145:1248-52.
27. Wells SA Jr, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994;220:237-47.